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Background. Reference values for visceral adipose tissue (VAT) are needed and it has been advocated that body composition
measures depend on both the technique andmethods applied, as well as the population of interest. We aimed to develop reference
values for VAT in absolute grams (VATg), percent (VAT%), and as a kilogram-per-meters-squared index (VATindex) for women
and men, and investigate potential differences between these measures and their associations with cardiometabolic risk factors
(including metabolic syndrome (MetS)).Methods. In the seventh survey of the population-based Tromsø Study, 3675 participants
(aged 40–84, 59% women) attended whole-body DXA scans (Lunar Prodigy GE) from where VAT was derived. We used
descriptive analysis, correlations, receiver operating characteristics (ROC), and logistic regression to propose reference values for
VATand investigated VAT’s association with cardiometabolic risk factors, MetS and single MetS components. Further, Youden’s
index was used to suggest threshold values for VAT. Results. VATg and VATindex increased until age 70 and then decreased, while
VAT% increased with age across all age groups. VAT (all measurement units) was moderate to highly correlated and significantly
associated with all cardiometabolic risk factors, except for total cholesterol. Associations between MetS, single MetS components,
and VATg and VATindex were similar, and VAT% did not contribute any further to this association. Conclusion. (ese VAT
reference values and thresholds, developed in a sample of adults of Norwegian origin, could be applied to other studies with
similar populations using the same DXA device and protocols. (e associations between VAT and cardiometabolic risk factors
were similar across different measurement units of VAT.
1. Introduction
(e definition of overweight and obesity is “abnormal or
excessive fat accumulation that may impair health” [1]. (e
most frequently used definitions of overweight and obesity
are based on anthropometric measures such as body mass
index (BMI) and waist circumference, which do not dis-
tinguish between fat mass and fat free mass, but rather
represent overall body size. On the contrary, available body
composition measures directly address the definition of
overweight and obesity. (ere are several tools to determine
body composition. Dual energy X-ray absorptiometry
(DXA) determines body composition from scanning the
body with X-ray beams that pass through the body and
establish amount of fat mass, bone mass, and soft tissue lean
mass based on composition of the tissues [2–4]. Visceral
adipose tissue (VAT) located intra-abdominally (behind the
abdominal muscles and around organs) is more metaboli-
cally active than subcutaneous adipose tissue and has been
associated with insulin resistance, the metabolic syndrome
(MetS), cardiovascular disease, and several types of cancer
[5]. DXA provides area-specific body composition, and VAT
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is estimated from fat mass located in the abdominal area
when subcutaneous fat has been removed [3]. DXA-derived
VAT has been validated against both MRI and CT [3, 6].
(ere are no generally accepted reference values for VAT.
Previous studies have presented normative data, and there is a
need for age-, sex-, and ethnicity-specific reference values
[7–9]. In addition, different types of DXA systems and models
as well as the type of unit used challenge VAT comparisons
across studies. (e most commonly parameters reported from
the DXA systems are VAT mass expressed in grams (VATg)
and VAT volume expressed in cubic centimeters (VATcm3).
(ere is a strong positive correlation between height and
weight, and likely also between height and VAT, and between
body fat and VAT. To increase comparability between indi-
viduals, it is of interest to adjust for potential confounding
effects of height and central adiposity, warranting relative VAT
values like VATindex (VAT/height2) and percent visceral fat in
the abdominal area (VAT%). Previous studies developing VAT
reference values have highlighted the importance of technique
and population-specific reference values [7].Most other studies
have used iDXA models [8, 10] or only included young adults
[9, 11]. In addition, few studies have investigated the associ-
ation between VAT and cardiometabolic risk factors
[7, 9, 11, 12].
We aimed to develop reference values for DXA-derived
VAT expressed in absolute and relative terms in an adult
population, predominantly of European origin from the
Tromsø Study, Norway. Additionally, we have investigated
the associations of distinct VAT parameters with car-
diometabolic risk factors, MetS and single MetS compo-
nents. Further, we present suggested threshold values of
VAT based on ability to predict MetS.
2. Materials and Methods
2.1. Study Population. (e Tromsø Study is an ongoing
population-based study [13] consisting of seven surveys
(Tromsø 1–7) conducted from 1974 to 2016, inviting large
representative samples of the population in the Tromsø
municipality in Northern Norway. We included participants
from Tromsø 7 (2015–2016) where all inhabitants aged 40
years and older (N= 32591) were invited to a basic exami-
nation including questionnaires, clinical measurements, and
biological sampling (Figure 1). A subsample (N= 13028) was
premarked for invitation to extended examinations ap-
proximately two weeks later. (is subsample consisted of a
randomized sample (N= 9925) as well as previous partici-
pants attending DXA, echocardiogram, and eye examina-
tions in Tromsø 6 (2007–2008) (N= 3103). A total of 21083
women and men aged 40–99 years attended the basic ex-
amination (65%), and 8346 attended the extended exami-
nations (of the premarked sample; 64% of the originally
premarked and 90% of those attending the basic exami-
nation). Of these, 3683 participated in DXA scans from
whom 3675 had VAT measures available (Figure 1).
(is project was approved by the Regional Committee
for Medical Research Ethics (REC North ref. 2017/1967),
and all participants gave written informed consent.
2.2. Study Measures. All measurements were performed by
trained staff using standard protocols.
2.2.1. Cardiometabolic Risk Factors. We included informa-
tion on diabetes and use of medications from self-administered
questionnaires. Nonfasting blood samples were analyzed for
total cholesterol (mmol/L), high-density lipoprotein (HDL)
cholesterol (mmol/L), triglycerides (mmol/L), and glycated
hemoglobin (HbA1c) (%), at the Department of Laboratory
Medicine at the University Hospital of North Norway (ISO
certification NS-EN ISO 15189 : 2012). Blood pressure was
measured three times with two-minute intervals with a
Dinamap ProCare 300 monitor (GE Healthcare, Norway) and
the mean of the two last readings was used in the analysis. We
usedMetS components based on the NCEP ATP III diagnostic
criteria for the MetS (2005 revision): hypertension (mean
systolic blood pressure >130mmHg and/or mean diastolic
blood pressure >85mmHg and/or use of antihypertensives),
high nonfasting blood lipids (triglycerides ≥1.7mmol/L and/or
use of lipid-lowering drugs), low HDL cholesterol (HDL
cholesterol <1.3 (women) or <1.0 (men) mmol/L and/or use of
lipid-lowering drugs), and diabetes (self-reported diabetes and/
or HbA1c≥ 6.5% and/or use of insulin and/or other diabetes
medication) [14]. As investigation of VAT was our main ob-
jective, we excluded elevated waist circumference as a criterion.
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Figure 1: Inclusion of participants.
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MetS was defined as presence of three or more of the MetS
components presented above, as defined by NCEP ATP III (n:
493 (24%) women and 406 (28%) men).
2.2.2. Adiposity Measures. Weight and height were mea-
sured with light clothing and no shoes to the nearest 0.1
kilograms (kg) and 0.1 centimeters (cm) using the Jenix DS-
102 height and weight scale (Dong Sahn Jenix, Seoul, Korea).
Waist and hip circumference were measured to the nearest
0.1 cm with a Seca measurement tape at the level of the
umbilicus and the greater trochanters, respectively. BMI
(weight in kg divided by height in meters (m) squared) was
defined as normal (<25 kg/m2), overweight (25–29.9 kg/m2),
or obese (≥30 kg/m2). (e 31 women and 2 men with un-
derweight (BMI <18.5 kg/m2) were merged with the normal
weight category.
Whole-body DXA scans (Lunar GE Prodigy Advance, GE
Medical Systems) were performed according to the manu-
facturer guidelines, by trained technicians who inspected the
postscan images and made relevant quality corrections to the
regions of interest according to a standardized protocol. (e
DXA device was calibrated each morning with a phantom
ahead of measurements. Total body fat in grams and per-
centage and android fat mass in grams were measured directly
by DXA, and VATg and VATcm3 were subsequently com-
puted by the validated CoreScan software (EnCore version
17.0). VAT%was calculated as 100 ∗ VATg divided by android
fat mass (g), and subcutaneous fat mass was calculated as
android fat mass (g)−VATg. VATindex was calculated as
VAT kg/height (m)2.
2.3. Statistical Analysis. We used STATA 16 (STATA Corp
LP, College Station, Texas, USA) to perform all analyses. P
values were considered significant at a 0.05 level. VATg and
VATcm3 were highly similar in all analyses; thus, we present
only VATg to represent absolute value.
A total of 3675 participants (58.6% women) aged 40–84
years were included (Figure 1). We used descriptive statistics
to present characteristics of the study population (Table 1).
VAT measures with value of 0 (n= 10) were transformed
into lowest value (2 g). To compare participants attending
only basic examination with those additionally attending
extended examinations, we used Student's t-test (Supple-
mentary Table 1). We present sex specific means with
standard deviations (SDs), confidence intervals (CIs), and
percentiles (5th, 25th, 50th, 75th, and 95th) by 10-year age
groups for VATg, VATindex, and VAT% (Supplementary
Tables 2–4). To explore the association with VAT (g, index
and %) and cardiometabolic risk factors, we used age-ad-
justed partial Pearson correlation coefficients (Table 2). To
investigate the ability of VAT to predict MetS and single
MetS components (hypertension, diabetes, elevated tri-
glycerides, and lowHDL cholesterol), we performed receiver
operating characteristic (ROC) analyses with presentation of
age-adjusted area-under-the-curves (AUCs) (Table 3). To
further explore if any of the included units of VAT were
better than the other in predicting MetS or single MetS
components, we used both log likelihood test
(Supplementary Table 5) and c-statistics (Supplementary
Table 6). As VATg and VATindex were not normally dis-
tributed, they were transformed to square root, and z-scores
were subsequently created for inclusion to the logistic re-
gression models to study their associations with MetS or
single MetS components. In addition, we stratified the an-
alyses of the association between z-scores of VAT (all units)
and the presence of MetS or single MetS components in
categories of BMI (normal weight, overweight, and obese)
(Table 4). Lastly, we used ROC analysis of VAT in prediction
of MetS to derive sensitivity and specificity. Further, we
applied Youden’s index ((sensitivity + specificity)-1) [15] to
present suggested threshold values of VAT based on esti-
mated optimal cutoffs (all units) (Table 5) [16]. We used
logistic regression analysis to present the odds for MetS for
each of the presented threshold values of VAT (all units)
(Table 5).
Normality distribution of VAT (g, index and %) was
checked by visual inspection (Figure 2). VATg and VAT-
index were positively skewed. We explored how mean VAT
(g, index and %) and mean subcutaneous fat change across
age (Figure 3). To investigate percentiles (5th, 25th, 50th, 75th,
and 95th) of VAT (g, index and %) over 10-year age groups,
we performed line plots with separate lines for each per-
centile (Figure 4).
3. Results
(e mean age was 66.2 (8.92) and 65.9 (9.13) years, and
mean BMI was 26.8 (4.70) and 27.6 (3.72) kg/m2, in women
and men, respectively (Table 1). (e mean age of the women
and men attending only basic examinations was 55.1 (10.9)
and 55.9 (11.1). Compared to the participants attending the
basic examinations only (Supplementary Table 2), those
attending the DXA scanning had lower body weight and
height. (ere were no differences in BMI or waist cir-
cumference in women and a small difference in BMI in men
(27.9 and 27.6 kg/m2, P � 0.007).
3.1. VAT Reference Values. VAT (all measurement units)
was higher in men than in women and increased up to age 70
in both genders (Supplementary Tables 2–4 and Figure 3).
(e exception was VAT%, which continued to increase after
attained age of 70–79 in women, while the curve flattened at
age 70–79 in men (Figure 3). Subcutaneous fat, however,
decreased rapidly after age group 70–79 in women and
decreased linearly with age in men, which explains why VAT
% continued to increase after age group 70–79, while both
VATg and VATindex decreased in women.(e investigation
of VAT (all measurement units) in percentiles (5th, 25th, 50th,
75th, and 95th) across age groups showed highly similar
patterns for VATg and VATindex in both women and men
(Figure 4). In women, the pattern of the 5th percentile (VATg
and VATindex) was quite consistent across age, while the
25th, 50th, and 75th percentile increased until age group
70–79 before it then slightly decreased (Figure 4). (e
pattern for the 95th percentile (VATg and VATindex) was
markedly higher and differed from the other percentiles. In
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addition, the 95th percentile (VATg and VATindex) in
women increased rapidly from age group 40–49 to age group
50–59, remained unchanged until age group 70–79, and
decreased thereafter (Figure 4). Percentiles of VAT% in
women increased across all age groups, with a steeper in-
crease from age group 40–49 to 50–59 (Figure 4).
In men, the pattern for VATg and VATindex 5th per-
centile was M-shaped across age groups (Figure 4). In the
25th and 50th percentiles, there was a small continuous in-
crease by age up to age group 70–79, while in the 75th and
95th percentiles, VATg and VATindex decreased from age
group 40–49 to 50–59, before it then increased up to age
group 70–79 and decreased thereafter. All percentiles for
VAT% increased over age groups in men, but the 75th and
the 95th percentile decreased after age 70–79 (Figure 4).
3.2. VAT and Metabolic Factors. Age-adjusted partial cor-
relation showed that VAT (all measurement units) was
positively associated with all cardiometabolic risk factors,
Table 2: Age-adjusted correlation for the association of VATg, VATindex, and VAT% with cardiometabolic risk factors: the Tromsø Study
2015–2016.
Cardiometabolic factors VATg VATindex VAT%
Women
Systolic blood pressure (mmHg) 0.12∗ 0.13∗ 0.10∗
Diastolic blood pressure (mmHg) 0.08∗ 0.08∗ 0.08∗
Triglycerides (mmol/L) 0.44∗ 0.44∗ 0.38∗
Total cholesterol (mmol/L) −0.006 −0.006 0.01
HDL cholesterol (mmol/L) −0.43∗ −0.43∗ −0.36∗
HbA1c (%) 0.24∗ 0.24∗ 0.17∗
CRP (mg/L) 0.14∗ 0.15∗ 0.09∗
Hypertension 0.20∗ 0.20∗ 0.15∗
Diabetes 0.23∗ 0.24∗ 0.16∗
Elevated triglycerides 0.35∗ 0.35∗ 0.31∗
Low HDL 0.28∗ 0.29∗ 0.24∗
Metabolic syndrome 0.29∗ 0.30∗ 0.24∗
Men
Systolic blood pressure (mmHg) 0.11∗ 0.11∗ 0.10∗
Diastolic blood pressure (mmHg) 0.13∗ 0.11∗ 0.12∗
Triglycerides (mmol/L) 0.38∗ 0.37∗ 0.31∗
Total cholesterol (mmol/L) −0.02 −0.03 −0.02
HDL cholesterol (mmol/L) −0.38∗ −0.37∗ −0.29∗
HbA1c % 0.27∗ 0.29∗ 0.19∗
CRP (mg/L) 0.08∗ 0.09∗ 0.03
Hypertension 0.25∗ 0.25∗ 0.21∗
Diabetes 0.22∗ 0.24∗ 0.18∗
Elevated triglycerides 0.34∗ 0.34∗ 0.28∗
Low HDL 0.25∗ 0.26∗ 0.20∗
Metabolic syndrome 0.30∗ 0.32∗ 0.23∗
∗P< 0.001.
Table 1: Descriptive of study population attending dual energy X-ray absorptiometry: the Tromsø Study 2015–2016.
Women (n� 2152) Men (n� 1523)
Age (years (% (n)) 66.2 (8.92) 65.9 (9.13)
40–49 5.95 (128) 6.70 (102)
50–59 13.2 (284) 12.3 (187)
60–69 43.3 (932) 47.4 (722)
70–79 32.1 (691) 27.5 (418)
80+ 5.44 (117) 6.17 (94)
Weight (kg) 71.3 (13.0) 86.0 (13.2)
Height (cm) 163.0 (6.25) 176.4 (6.70)
BMI (kg/m2) 26.8 (4.70) 27.6 (3.72)
VAT (g), mean (SD) 936.7 (632.5) 1660.9 (876.6)
VAT (g), median (25p–75p) 832 (444–1302.5) 1578 (1004–2222)
VAT (index), mean (SD) 0.35 (0.24) 0.53 (0.28)
VAT (index), median (25p–75p) 0.32 (0.16–0.49) 0.51 (0.33–0.71)
VAT (%), mean (SD) 37.1 (13.6) 60.2 (14.2)
VAT (%), median (25p–75p) 37.8 (28.3–46.7) 61.2 (52.0–69.9)
Presented as proportion (n) or mean (SD). VAT (all measurement units) is also presented as median with 25–75th percentile. VAT index: VATkg/height (m)2.
4 Journal of Obesity
except for HDL that was negatively associated with VAT,
and total cholesterol that was not significantly associated
(Table 2).
When comparing the ability of VATg, VATindex, and
VAT% to predict MetS and single MetS components, all
AUCs were high (≥0.67). AUCs of VATg and VATindex
were consistently higher than AUCs of VAT% (Table 3).
When comparing log likelihood/fit of age-adjusted
regression models by adding different VAT measurement
units to the model with MetS and single MetS components,
VATg and VATindex were the most important predictors
(Supplementary Table 5). C-statistics revealed no significant
differences between predictions of single MetS components
from the different VATmeasurement units (Supplementary
Table 6). In prediction of MetS, there were significant dif-
ferences by adding both VAT% and VATindex to the model
Table 3: AUC from different age-adjusted models with VAT (g), VAT (%), or VAT (index) in prediction of metabolic syndrome and single
metabolic components: the Tromsø Study 2015–2016.
Dependent variables
Women Men
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
Hypertension 0.77 0.77 0.77 0.73 0.72 0.73
Diabetes 0.72 0.70 0.72 0.75 0.73 0.76
Elevated triglycerides 0.73 0.71 0.73 0.71 0.67 0.71
Low HDL 0.69 0.67 0.69 0.70 0.68 0.70
Metabolic syndrome 0.73 0.71 0.73 0.75 0.73 0.76
Independent: Model 1: age and VATg, Model 2: age and VAT%, Model 3: age and VATindex. Numbers indicating AUC for the model.
Table 4: Age-adjusted OR for the association of metabolic syndrome and single metabolic components and standardized/z-scores of VAT
mass in categories of body mass index (BMI): the Tromsø Study 2015–2016.
Metabolic
factors





































































































































































































Women: VATg SD: 632.5; VATindex SD: 0.24; VAT% SD: 13.6. Men: VATg SD: 876.6; VATindex SD: 0.28; VAT% SD: 14.2.
Table 5: Suggested threshold values of VATderived from Youden’s index and odds for metabolic syndrome: the Tromsø Study 2015–2016.
Women Men
(reshold OR (95% CI) Youden’s index (reshold OR (95% CI) Youden’s index
VAT (g) ≥1134 3.63 (2.94–4.49) 0.297 ≥1859 4.03 (3.17–5.13) 0.331
VAT (index) ≥0.44 4.04 (3.26–4.99) 0.321 ≥0.55 4.02 (3.15–5.13) 0.336
VAT (%) ≥40.3 3.36 (2.72–4.15) 0.298 ≥61.2 3.12 (2.44–3.97) 0.276
OR: odds ratio; CI: confidence interval.
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with VATg (P≤ 0.04 for both), but the AUCs were identical
in women and only slightly different in men (Supplementary
Table 6).
When investigating associations between z-score of VAT
(all measurement units) and MetS and single MetS com-
ponents in categories of BMI, the majority of associations
showed significantly higher odds with increasing VAT. (e
pattern showed highest odds for elevated triglycerides with
increasing VAT, in most categories of BMI in women, while
the odds for diabetes were highest in most categories of BMI
in men (Table 4). With regard to BMI differences, in women
the highest odds for hypertension and elevated triglycerides in
all z-score units of VAT were observed in the overweight
category and the highest odds for diabetes, low HDL cho-
lesterol, and MetS were observed in the obese category. (e
only exception was z-scores of VATindex in association with
low HDL cholesterol which was highest in the overweight
category (Table 4). In men, the highest odds for MetS and all
MetS components were observed in the overweight category
according to all z-score units of VAT (Table 4). (e different
z-score units of VAT and associations with MetS and MetS
components were similar, although higher odds were observed
in z-scores of VATg and VATindex compared to VAT%.
Based on Youden’s index and the abilities to predict MetS,
suggested thresholds of VATg, VATindex, and VAT% in
women are ≥1134, ≥0.44, and≥ 40.3, respectively, with
corresponding odds for MetS of 3.63, 4.04, and 3.36, re-
spectively. In men, suggested thresholds and odds for MetS
were ≥1859 (OR: 4.03), ≥0.55 (OR: 4.02), and ≥61.2 (OR:
3.12), for VATg, VATindex, and VAT%, respectively
(Table 5).
4. Discussion
Measures of VAT (expressed in absolute and derived variables)
were positively associated with age, MetS, and single MetS
components. VATg and VATindex consistently showed slightly
stronger associations with MetS and single MetS components
than VAT%, but overall, the associations were similar.
Because the distribution of fat, and especially VAT ac-
cumulation in abdominal area, rather than overall fat mass
has been highlighted as the most robust predictor for car-
diometabolic disease, it is valuable to determine reference
values for VAT [17]. Relative measures (e.g., waist-to-height
ratio) may be stronger predictors for disease than absolute
measures (e.g., waist circumference) [18, 19], and it is
therefore also relevant to assess whether relative measures of
VATaremore strongly correlated withMetS and singleMetS
components than absolute measures.
We observed higher VATg in percentiles for both
women and men as compared to other studies [9, 10].
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Figure 2: Normality curves of VAT (g), VAT (index), and VAT (%).
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years) and Hirsch et al. [10] used the next-generation DXA
(iDXA), in addition to presenting different age groups than
us (25–49 years and 50+ years), thus limiting direct com-
parison of results.
Our age-adjusted partial correlations were similar to
those found by Rothney et al. [12], who used the iDXA
system to study associations between VATg and
cardiometabolic risk factors. Miazgowski et al. [9] found
stronger correlations between VATg and cardiometabolic
risk factors, than in our analysis, but the AUCs observed in
the present study are higher. Miazgowski et al. [9] did,
however, not adjust for age and presented cardiometabolic
risk factors in different units than the present study; thus






































































































































































































Figure 3: VAT (g, index, and %) and subcutaneous fat (g) in android region over age: the Tromsø Study 2015–2016.
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VATg and VATindex decreased rapidly after the age of
70 years. A similar decrease in VAT after age 70 years was
found in a study from the United States (using iDXA) [8],
which suggested that this decrease could be explained by the
small number of participants in the oldest population. (is
decreasing pattern after age 70 was, however, not confirmed
by a larger population-based study (n= 10 984) from
Ofenheimer et al. [7], conducted in Austria using the system
Lunar Prodigy system. Among our participants, 1320 (61%
women) were 70 years and older, and together with a high
attendance among the older population in the Tromsø Study
[20], we conclude that the decrease presented in this study
cannot be explained by low participation. Although we did
not have the opportunity to investigate potential anthro-
pometric differences in nonattenders, we did compare the
population only attending basic examinations, with those
also attending extended examinations (DXA) and found no
clinically or statistically significant differences in BMI or
waist circumference. Previous studies investigating longi-
tudinal change in BMI and waist circumference in the
Tromsø Study population showed that adiposity increases
with age, with a larger increase in the younger compared to
the older birth cohorts [21–23]. One might hypothesize that
central adiposity is less prevalent in the older than younger
age groups in the present population. Body composition
changes with age as total lean mass decreases, fat mass
increases, and a greater proportion of fat accumulates within
the abdomen as visceral fat [24]. (is was reflected in the
present study as VAT% (particularly in women) increased
continuously, while VATg decreased after age 70. (is ob-
servation is due to VATg decreasing relatively less than
subcutaneous fat. A somewhat surprising finding was the
steep decline in subcutaneous fat in women older than 70
years, compared to the linear decrease observed in men.
All cardiometabolic risk factors except total cholesterol
showed statistically significant associations with VAT.
Similar findings were observed in previous studies inves-
tigating the associations between DXA-derived VAT and
cardiometabolic risk factors [9, 12, 25]. We could, however,
find no other studies comparing how the different mea-
surement units of VATperformed in their associations with
MetS and single MetS components. Further, the threshold
values were higher for men than women. Although one
might expect absolute threshold values to be higher for
men, it is quite interesting that the relative measures are
also higher, indicating that men might tolerate a higher
amount of VAT relative to body size before it becomes a
risk for MetS.
To the best of our knowledge, this is the first study pre-
senting reference values for VATindex and VAT% in addition
to suggested threshold values for VAT (all units) in association
with MetS. (erefore, the results presented are of importance
to future studies utilizing DXA-derived VATand may support
clinicians, who use DXA in their daily routine, to make de-
cisions on whether to initialize interventions for patients with
abdominal obesity. Although previous studies have presented
reference values for VAT in grams, it is highly important to
complement previous proposed reference values and also to
present reference values for measures that address VAT in
relation to overall body size (VATindex andVAT%). It has long
been known that VAT is of particular concern to car-
diometabolic health, and tracking VAT as a representative for
overweight and obesity is a more accurate indicator of the
health status than traditional anthropometric measures such as
BMI or waist circumference. (e current study enables
comparison with future studies aiming at presenting reference
values and threshold values of VAT. We emphasize that the
reference values and thresholds presented are applicable only to
similar populations andmeasures from similar equipment as in
the present study. Future studies are needed to confirm the
thresholds suggested in our population.
4.1. StrengthsandLimitations. Amajor strength of this study
is the wide age range of participants, providing proposed
VAT reference values in adults aged 40 and older. Further,
we could investigate VAT’s association with both MetS and
single MetS components and propose threshold values for
VAT (all units) based on sensitivity and specificity in pre-
diction of MetS. Because of the population-based design,
where fasting blood samples are unusual, we did not include
fasting glucose as an indicator for diabetes, but rather self-
reported diabetes, medication use, or HbA1c≥ 6.5% which
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Figure 4: Quantities of VAT (g), VAT (index), and VAT (%) in 10-year age groups in women and men: the Tromsø Study 2015–2016.
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diabetes. We did not have the opportunity to examine
whether the study participants differed from nonattenders.
We did however compare those attending only the basic
examination of the survey to those included in this analysis
and found no differences according to waist circumference
or BMI, and together with the high attendance we conclude
that our study is representative of the general population. It
should be emphasized that the references derived here (from
Lunar Prodigy in age group 40–84 in a Norwegian pop-
ulation) may not be directly comparable to reference values
derived from other manufacturers, DXA equipment, age
groups, or populations/ethnicities, but to similar pop-
ulations and methods used in the current study.
5. Conclusions
DXA-derived VATg and VATindex increased with age up to
70 years, while VAT% increased continuously with age. (e
percentiles presented (5th, 12th, 50th, 75th, and 95th) and
suggested thresholds of VATg, VATindex, and VAT% can be
used for comparison with studies of similar populations
using the same technology. All VAT measurement units
except total cholesterol showed statistically significant as-
sociations with cardiometabolic risk factors. Results did not
substantially differ between measurements units of VAT;
thus, any measurement unit seems acceptable to use.
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